Carbamazepine enhances brain production of kynurenic acid in vitro

Eur J Pharmacol. 2004 Sep 13;498(1-3):325-6. doi: 10.1016/j.ejphar.2004.07.088.

Abstract

Disturbed formation of kynurenic acid, an endogenous antagonist of glutamate ionotropic receptors, might contribute to the pathogenesis of seizures. Here, the effect of anticonvulsant drug, carbamazepine on the production of kynurenic acid was studied. Carbamazepine (0.5-3 mM) enhanced kynurenic acid synthesis in rat cortical slices and also increased the activity of kynurenine aminotransferase (KAT) I at 0.1-3.0 mM concentration. Thus, anticonvulsant drugs, such as carbamazepine, might act partially via stimulation of kynurenic acid production.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Anticonvulsants / pharmacology*
  • Brain / drug effects*
  • Brain / enzymology
  • Brain / metabolism
  • Carbamazepine / pharmacology*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / enzymology
  • Cerebral Cortex / metabolism
  • Chromatography, High Pressure Liquid
  • Dose-Response Relationship, Drug
  • In Vitro Techniques
  • Isoenzymes / metabolism
  • Kynurenic Acid / metabolism*
  • Kynurenine / pharmacology
  • Male
  • Rats
  • Rats, Wistar
  • Transaminases / metabolism

Substances

  • Anticonvulsants
  • Isoenzymes
  • Carbamazepine
  • Kynurenine
  • Transaminases
  • kynurenine-oxoglutarate transaminase
  • Kynurenic Acid